Treatment of liver metastases in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis

Abstract

Cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have gained increasing consensus in treatment of peritoneal carcinomatosis from colorectal cancer. The presence of liver metastases is generally considered a contraindication for CS + HIPEC, as hepatic involvement no longer represents a loco-regional aspect of disease. Despite this, liver resection (LR) has been tested in selected cases in combination with CS + HIPEC for treatment of peritoneal carcinomatosis with liver metastasis. Relevant studies on this topic were identified through a search in the electronic PubMed database, using the appropriate keywords. CS + HIPEC + LR allows similar outcomes in terms of survival and morbidity with respect to CS + HIPEC, especially in patients with low tumor load. CS + HIPEC + LR represents a reasonable approach for patients with peritoneal carcinomatosis and liver metastases from colorectal cancer. Patients should be selected in high volume tertiary centres, preferably in the context of a prospective trial.

Keywords

Colorectal cancer / peritoneal carcinomatosis / liver metastases / hyperthermic intraperitoneal chemotherapy / liver resection

References

[1] Sadeghi B,Glehen O,Rivoire M,Fontaumard E,Caillot JL,Porcheron J,François Y,Gilly FN.Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study..Cancer2000;88:358-63

[2] Jayne DG,Loi C.Peritoneal carcinomatosis from colorectal cancer..Br J Surg2002;89:1545-50

[3] Chu DZ,Thompson C,Westbrook KC.Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors..Cancer1989;63:364-7

[4] Golfinopoulos V,Pavlidis N.Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis..Lancet Oncol2007;8:898-911

[5] Chua TC,Saxena A,Liauw W,Germer CT,Pelz JO.Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study..Ann Surg Oncol2011;18:1560-7

[6] Elias D,Chevalier J,Marchal F,Ferron G,Meeus P,Bonastre J.Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin..J Clin Oncol2009;27:681-5

[7] Chua TC,Pelz JO.Summary of current therapeutic options for peritoneal metastases from colorectal cancer..J Surg Oncol2012;107:566-73

[8] Nordlinger B,Glimelius B,Schlag PM,Bechstein WO,Walpole ET,Jaeck D,Parks RW,Praet M,Van Cutsem E,Gruenberger T.Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial..Lancet2008;371:1007-16

[9] Yedibela S,Feuchter K,Meyer T,Göhl J.Surgical management of pulmonary metastases from colorectal cancer in 153 patients..Ann Surg Oncol2006;13:1538-44

[10] Sugarbaker PH.Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy..Ann Surg1995;221:124-32

[11] Carpizo DR.Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease..Ann Surg Oncol2009;16:2411-21

[12] Elias D,Pocard M,Boige V,Pignon JP.Results of R0 resection for colorectal liver metastases associated with extrahepatic disease..Ann Surg Oncol2004;11:274-80

[13] Elias D,Vernerey D,Ducreux M,Malka D,Lasser P.Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect..Ann Surg Oncol2005;12:900-9

[14] Aoki T,Tanaka S,Warabi M.Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin..Surgery2008;143:706-14

[15] Byam J,Woodall CE,McMasters KM.Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation?.Ann Surg Oncol2009;16:3064-9

[16] Tomlinson JS,DeMatteo RP,Kornprat P,Kemeny N,Blumgart LH.Actual 10-year survival after resection of colorectal liver metastases defines cure..J Clin Oncol2007;25:4575-80

[17] Verwaal VJ,de Bree E,van Tinteren H,Zoetmulder FA.Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer..J Clin Oncol2003;21:3737-43

[18] Glehen O,Sugarbaker PH,Levine EA,Barone R,Cavaliere F,Gutman M,Lorimier G,Bereder JM,Gomez-Portilla A,Deraco M.Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study..J Clin Oncol2004;22:3284-92

[19] Elias D,Boutitie F,Bereder JM,Lorimier G,Glehen O.Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study..J Clin Oncol2010;28:63-8

[20] Elias D,Goéré D,Honoré C,Malka D.A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases..Ann Surg Oncol2014;21:2052-8

[21] Allard MA,Ruiz A,Paule B,Sebagh M,Azoulay D.Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively..Eur J Surg Oncol2013;39:981-7

[22] Dunne DF,Jones RP,Sutton PA,Poston GJ.Routine staging laparoscopy has no place in the management of colorectal liver metastases..Eur J Surg Oncol2013;39:721-5

[23] Khan AZ.The impact of staging laparoscopy prior to hepatic resection for colorectal metastases..Eur J Surg Oncol2007;33:1010-3

[24] Cao C,Black D.A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin..Ann Surg Oncol2009;16:2152-65

[25] Esquivel J.Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea..Cancer J2009;15:249-54

[26] Carmignani CP,Sugarbaker PH.The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer..Eur J Surg Oncol2004;30:391-8

[27] Kianmanesh R,Sabate JM,Pons-Kerjean N,Hay JM,Msika S.Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases..Ann Surg2007;245:597-603 PMCID:PMC1877034

[28] Franko J,Holtzman MP,Jones HL,Bartlett DL.Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer..Ann Surg Oncol2008;15:3065-72

[29] Varban O,Stewart JH,Shen P.Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases..Cancer2009;115:3427-36

[30] Duraj FF.Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study..J Gastrointest Oncol2013;4:388-96 PMCID:PMC3819769

[31] Chua TC,Zhao J.Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection..Eur J Surg Oncol2009;35:1299-305

[32] Navez J,Leonard D,Kartheuser A,Coubeau L,Van den Eynde M,Jabbour N.Surgical treatment of colorectal cancer with peritoneal and liver metastases using combined liver and cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: report from a single-centre experience..Ann Surg Oncol2016;23:666-73

[33] Chua TC,Saxena A.Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure: a systematic review of morbidity and mortality..Ann Surg2009;249:900-7

[34] House MG,Gönen M,Allen PJ,Brennan MF,Jarnagin WR.Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution..J Am Coll Surg2010;210:744-52, 752-5

[35] Paun BC,MacLean AR,Buie WD.Postoperative complications following surgery for rectal cancer..Ann Surg2010;251:807-18

[36] Elias D,Pocard M,Boige V.Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer..Eur J Surg Oncol2006;32:632-6